Zurzuvae PPD denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for zurzuvae ppd are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Applies Step Therapy to Zurzuvae for PPD

Step therapy (sometimes called "fail-first") requires that a patient try and fail one or more lower-cost or better-established medications before Aetna will authorize coverage of Zurzuvae (zuranolone). For postpartum depression, Aetna's step-therapy protocol typically requires documented trials of one or more formulary antidepressants. This denial is issued when Aetna's records do not reflect an adequate prior trial of a required step-therapy agent, even if the patient has in fact tried one or more alternatives.

## Why This Denial Is Appealable

Step-therapy denials are among the most commonly appealed and reversed pharmacy denials. Grounds for appeal include: (1) the patient already tried the required step(s) but it was not documented in the claim record; (2) the required step drug is contraindicated, clinically inappropriate, or previously caused an adverse reaction per the chart; (3) the patient's clinical condition requires prompt effective treatment such that step-therapy delay poses a health risk; or (4) the step-therapy requirement violates applicable state step-therapy reform law. Many states, including states where Aetna fully-insured plans are issued, have enacted step-therapy override statutes — check whether your state's law applies.

## Federal and State Appeal Framework

• Step-therapy override / exception request: File with Aetna's pharmacy or medical management department with full supporting documentation before or alongside a formal appeal.
• Internal appeal (ACA §2719 / ERISA §503): Submit within the deadline in your denial letter. For pre-service step-therapy disputes, Aetna must respond within 15 days standard or 72 hours expedited.
• State step-therapy override law: If your plan is fully insured and your state has a step-therapy override statute, cite it explicitly in your appeal. Many such laws require override within a defined number of days when specific clinical criteria are met.
• External review: After final internal denial, you have approximately 4 months to request independent external review under ACA §2719.
• Expedited option: Request expedited processing if delay poses a serious health risk — this is often clinically relevant in the postpartum period.

## Documentation to Gather

1. Prior-treatment history (the most important document): A comprehensive list of every antidepressant previously tried, with start and stop dates, prescribing clinician, and documented outcome — including why the medication was stopped (lack of efficacy, adverse effect, or clinical contraindication per the prescriber). 2. Step-therapy override grounds documentation: If the required step drug is contraindicated, obtain a prescriber statement explaining the clinical basis, referencing the FDA-approved prescribing label for the relevant drug. 3. Diagnosis and severity confirmation: DSM-5 PPD diagnosis, severity documentation, and any safety concerns documented in the chart that support the need for prompt effective treatment. 4. Medical-necessity letter for Zurzuvae: Prescriber letter explaining why Zurzuvae is the appropriate next step given the patient's treatment history and current clinical status, with reference to the FDA-approved indication and the applicable professional society guideline. 5. Aetna's step-therapy criteria: Obtain the exact step-therapy requirements in writing and map each to the chart evidence in your appeal.

## Criteria-Mapping Structure

In your appeal letter, address each required step:

• Step required by Aetna (verbatim): [paste exact language]
• Patient's history with this agent: [dates tried, outcome, reason stopped — from chart and prescriber attestation]
• Override ground (if applicable): [clinical contraindication per label, adverse reaction per chart, state law citation]

Attach pharmacy records, chart notes, and the prescriber letter as labeled exhibits. A well-documented step-therapy appeal that maps prior trials or clinical override grounds to every required step has a strong foundation for reversal.